Different efficacy of soluble CD14 treatment in high- and low-dose LPS models

被引:0
|
作者
Stelter, F
Witt, S
Fürll, B
Jack, RS
Hartung, T
Schütt, C
机构
[1] Univ Greifswald, Inst Immunol & Transfus Med, D-17487 Greifswald, Germany
[2] Univ Konstanz, D-7750 Constance, Germany
关键词
CD14; Kupffer cells; lipopolysaccharide; liver damage; soluble CD14; septic shock;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background About 50% of septic shock cases are attributed to Gram-negative bacteria or their cell wall compound lipopolysaccharide (LPS, endotoxin). An attractive therapeutic strategy could target the binding of LPS to its cellular receptors. In vitro the soluble form of the endotoxin receptor CD14 (sCD14) competitively prevents binding of LPS to membrane-bound CD14 and inhibits LPS-stimulated macrophage responses. Methods We tested the in vivo endotoxin-neutralizing capacity of human recombinant sCD14 using a mouse model of shock induced by 8 mu g g(-1) of LPS from Salmonella abortus equi. Results In this model, treatment with sCD14 reduced mortality if administered before or simultaneously with LPS. However, application of sCD14 had no effect on the secretion of early proinflammatory cytokines and did not protect the animals against the development of apparent shock symptoms and liver injury. sCD14 also failed to prevent LPS-inducible (7.5 ng g(-1)) liver injury in galactosamine-sensitized mice. Conclusion In line with these findings, sCD14 did not block LPS-induced activation of Kupffer cells in vitro, which might explain why the compound only partially protected in vivo.
引用
收藏
页码:205 / 213
页数:9
相关论文
共 50 条
  • [1] Endotoxin (lipopolysaccharide; LPS) activates cultured human mesangial cells by means of the LPS receptor CD14 (soluble CD14)
    Loppnow, H
    Stelter, F
    VonderOhe, J
    Resch, K
    Rietschel, ET
    Flad, HD
    Uciechowski, P
    EUROPEAN JOURNAL OF CELL BIOLOGY, 1997, 72 : 309 - 309
  • [2] Structure/function relationships of human CD14: Analysis of LPS-binding to membrane bound CD14 and LPS-induced signaling mediated by soluble CD14
    Stelter, F
    Bernheiden, M
    Menzel, R
    Jack, RS
    Witt, S
    Fan, X
    Schutt, C
    4TH INTERNATIONAL CONGRESS ON THE IMMUNE CONSEQUENCES OF TRAUMA, SHOCK AND SEPSIS: MECHANISMS AND THERAPEUTIC APPROACHES, 1996, : 21 - 25
  • [3] Roles for LBP and soluble CD14 in cellular uptake of LPS
    Tapping, RI
    Gegner, JA
    Kravchenko, VV
    Tobias, PS
    ENDOTOXIN AND SEPSIS: MOLECULAR MECHANISMS OF PATHOGENESIS, HOST RESISTANCE, AND THERAPY, 1998, 397 : 73 - 78
  • [4] Mechanisms of LPS inhibition by soluble CD14, LBP, and lipoproteins
    Kitchens, RL
    Thompson, PA
    SHOCK, 2004, 21 : 60 - 60
  • [5] Dual effects of soluble CD14 on LPS priming of neutrophils
    Troelstra, A
    Giepmans, BNG
    VanKessel, KPM
    Lichenstein, HS
    Verhoef, J
    VanStrijp, JAG
    JOURNAL OF LEUKOCYTE BIOLOGY, 1997, 61 (02) : 173 - 178
  • [6] IDENTIFICATION OF A DOMAIN IN SOLUBLE CD14 ESSENTIAL FOR LIPOPOLYSACCHARIDE (LPS) SIGNALING BUT NOT LPS BINDING
    JUAN, TSC
    HAILMAN, E
    KELLEY, MJ
    WRIGHT, SD
    LICHENSTEIN, HS
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (29) : 17237 - 17242
  • [8] Catalytic properties of lipopolysaccharide (LPS) binding protein - Transfer of LPS to soluble CD14
    Yu, B
    Wright, SD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (08) : 4100 - 4105
  • [9] Characteristics of CD14 shedding from human monocytes - Evidence for the competition of soluble CD14 (sDC14) with CD14 receptors for lipopolysaccharide (LPS) binding
    Rokita, E
    Menzel, EJ
    APMIS, 1997, 105 (07) : 510 - 518
  • [10] Detection of the receptor for complexes of lipopolysaccharide (LPS)-soluble CD14 (sCD14).
    Vita, N
    Lefort, S
    Reeb, R
    Sozzani, P
    Richards, S
    Borysiewicz, LK
    Ferrara, P
    Labeta, MO
    IMMUNOLOGY, 1996, 89 : N143 - N143